Cite
HARVARD Citation
Goel, A. et al. (2019). Daclatasvir and reduced‐dose sofosbuvir: An effective and pangenotypic treatment for hepatitis C in patients with estimated glomerular filtration rate <30 mL/min. Nephrology. 24 (3), pp. 316-321. [Online].